Sound Income Strategies LLC Boosts Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sound Income Strategies LLC lifted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 43.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 347,841 shares of the medical instruments supplier's stock after acquiring an additional 105,777 shares during the quarter. Sound Income Strategies LLC owned 0.17% of DENTSPLY SIRONA worth $5,197,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in XRAY. Blue Trust Inc. lifted its holdings in shares of DENTSPLY SIRONA by 22.6% in the 4th quarter. Blue Trust Inc. now owns 7,959 shares of the medical instruments supplier's stock worth $151,000 after acquiring an additional 1,467 shares during the last quarter. State of New Jersey Common Pension Fund D lifted its holdings in shares of DENTSPLY SIRONA by 41.7% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 111,184 shares of the medical instruments supplier's stock worth $2,110,000 after acquiring an additional 32,720 shares during the last quarter. Sanctuary Advisors LLC acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $255,000. Alberta Investment Management Corp acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $2,574,000. Finally, Ieq Capital LLC acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $2,334,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Down 2.4%

Shares of XRAY traded down $0.38 during midday trading on Friday, reaching $15.63. The stock had a trading volume of 1,408,937 shares, compared to its average volume of 2,971,156. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $27.95. The company's fifty day simple moving average is $14.85 and its two-hundred day simple moving average is $16.84. The company has a market cap of $3.11 billion, a price-to-earnings ratio of -7.55, a PEG ratio of 1.80 and a beta of 0.95. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The business had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company's revenue was down 7.8% on a year-over-year basis. During the same period last year, the business earned $0.42 EPS. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.09%. The ex-dividend date of this dividend is Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.10%.

Analyst Ratings Changes

A number of research firms have issued reports on XRAY. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a report on Tuesday, April 15th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a report on Friday, February 28th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Finally, Barrington Research increased their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an "outperform" rating in a report on Monday, May 12th. Eleven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $20.36.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.